Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1585638

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1585638

Biological Safety Cabinet Market by Type (Class I, Class II, Class III), End User (Academic & Research Organizations, Diagnostics & Testing Laboratories, Pharmaceutical & Biopharmaceutical Companies) - Global Forecast 2025-2030

PUBLISHED:
PAGES: 182 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Biological Safety Cabinet Market was valued at USD 456.46 million in 2023, expected to reach USD 494.74 million in 2024, and is projected to grow at a CAGR of 8.47%, to USD 806.93 million by 2030.

A Biological Safety Cabinet (BSC) is an enclosed, ventilated lab workspace designed to protect both the user and the environment from pathogenic microorganisms, with applications spanning biomedical, pharmaceutical, and biotechnological research. The necessity of BSCs is underscored by their critical role in ensuring biosafety and preventing contamination in laboratories, industrial settings, and healthcare facilities. The application and end-use scope are vast, extending from research institutions and clinical laboratories to hospitals and pharmaceutical companies, with increasing adoption driven by the need for stringent safety standards amid global health threats like COVID-19. Significant growth factors influencing the BSC market include the rise of infectious diseases, escalating biosecurity concerns, and stringent regulatory frameworks regarding laboratory personnel safety. Technological advancements, such as improved airflow systems and advanced filtration technologies, offer potential growth opportunities, along with increased investment in R&D and healthcare infrastructure, particularly in emerging markets. However, market growth faces challenges such as high initial costs, complex maintenance requirements, and a lengthy approval process from regulatory bodies, which may deter small-scale labs from adopting BSCs. To capitalize on emerging opportunities, companies can focus on areas of innovation, such as developing energy-efficient models, integrating digital monitoring systems, and exploring eco-friendly materials in design and manufacturing. Encouraging partnerships and collaborations with research institutions can also drive forward innovative solutions. The market presents a moderately competitive landscape with key players consistently innovating to maintain market presence and comply with evolving safety standards. Enterprises aiming for business growth should invest in robust R&D strategies, tap into emerging markets, and offer customization to meet specific lab requirements. This research-centered innovation approach could help in overcoming the existing market challenges and cater to the growing biosafety cabinet demand effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 456.46 million
Estimated Year [2024] USD 494.74 million
Forecast Year [2030] USD 806.93 million
CAGR (%) 8.47%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biological Safety Cabinet Market

The Biological Safety Cabinet Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Favorable regulations driving the use of biological safety cabinets in the healthcare industry
    • Increased risk of pandemics and communicable diseases
    • Rapid growth in the number of biologics
  • Market Restraints
    • Alternative containment cabinet
  • Market Opportunities
    • Increasing number of R&D activities in biopharmaceutical and pharmaceutical companies
    • Rapid growth in the number of biologics increased investment in healthcare infrastructure in growing economies
  • Market Challenges
    • Development of low cost high quality biological safety cabinets

Porter's Five Forces: A Strategic Tool for Navigating the Biological Safety Cabinet Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biological Safety Cabinet Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biological Safety Cabinet Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biological Safety Cabinet Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biological Safety Cabinet Market

A detailed market share analysis in the Biological Safety Cabinet Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biological Safety Cabinet Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biological Safety Cabinet Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biological Safety Cabinet Market

A strategic analysis of the Biological Safety Cabinet Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biological Safety Cabinet Market, highlighting leading vendors and their innovative profiles. These include Air Science USA LLC by PyroGenesis Canada Inc., Alpha Linear, Berner International GmbH, Biobase Biodusty (Shandong), Co., Ltd., Esco Micro Pte. Ltd., EuroClone S.p.A., Flow Sciences, Inc., Germfree Laboratories, Inc., Haier Biomedical, Kewaunee Scientific Corporation, Labconco Corporation, Stericox India Private Limited, The Baker Company, Thermo Fisher Scientific Inc., and TopAir Systems Inc..

Market Segmentation & Coverage

This research report categorizes the Biological Safety Cabinet Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Class I, Class II, and Class III. The Class II is further studied across Class II Type A and Class II Type B.
  • Based on End User, market is studied across Academic & Research Organizations, Diagnostics & Testing Laboratories, and Pharmaceutical & Biopharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-437D4595793A

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Favorable regulations driving the use of biological safety cabinets in the healthcare industry
      • 5.1.1.2. Increased risk of pandemics and communicable diseases
      • 5.1.1.3. Rapid growth in the number of biologics
    • 5.1.2. Restraints
      • 5.1.2.1. Alternative containment cabinet
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing number of R&D activities in biopharmaceutical and pharmaceutical companies
      • 5.1.3.2. Rapid growth in the number of biologics increased investment in healthcare infrastructure in growing economies
    • 5.1.4. Challenges
      • 5.1.4.1. Development of low cost high quality biological safety cabinets
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biological Safety Cabinet Market, by Type

  • 6.1. Introduction
  • 6.2. Class I
  • 6.3. Class II
    • 6.3.1. Class II Type A
    • 6.3.2. Class II Type B
  • 6.4. Class III

7. Biological Safety Cabinet Market, by End User

  • 7.1. Introduction
  • 7.2. Academic & Research Organizations
  • 7.3. Diagnostics & Testing Laboratories
  • 7.4. Pharmaceutical & Biopharmaceutical Companies

8. Americas Biological Safety Cabinet Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biological Safety Cabinet Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biological Safety Cabinet Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Air Science USA LLC by PyroGenesis Canada Inc.
  • 2. Alpha Linear
  • 3. Berner International GmbH
  • 4. Biobase Biodusty (Shandong), Co., Ltd.
  • 5. Esco Micro Pte. Ltd.
  • 6. EuroClone S.p.A.
  • 7. Flow Sciences, Inc.
  • 8. Germfree Laboratories, Inc.
  • 9. Haier Biomedical
  • 10. Kewaunee Scientific Corporation
  • 11. Labconco Corporation
  • 12. Stericox India Private Limited
  • 13. The Baker Company
  • 14. Thermo Fisher Scientific Inc.
  • 15. TopAir Systems Inc.
Product Code: MRR-437D4595793A

LIST OF FIGURES

  • FIGURE 1. BIOLOGICAL SAFETY CABINET MARKET RESEARCH PROCESS
  • FIGURE 2. BIOLOGICAL SAFETY CABINET MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIOLOGICAL SAFETY CABINET MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIOLOGICAL SAFETY CABINET MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOLOGICAL SAFETY CABINET MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOLOGICAL SAFETY CABINET MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II TYPE A, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II TYPE B, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY ACADEMIC & RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY DIAGNOSTICS & TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. BIOLOGICAL SAFETY CABINET MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. BIOLOGICAL SAFETY CABINET MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!